The BSH Guidelines Official Podcast
Health & Fitness:Medicine
Dr Rachel Rayment presents a podcast on the BSH The use of prophylactic factor replacement for children and adults with Haemophilia A and B.
Coagulation factor replacement in people with haemophilia (PWH) A or B may be given either in response to a bleed [on‐demand (OD) therapy] or regularly to prevent bleeding (prophylactic therapy). Guidelines for prophylactic treatment of children and adults with severe haemophilia A (SHA) were produced by the United Kingdom Haemophilia Centre Doctors’ Organisation (UKHCDO) in 2010, summarising the high‐level, evidence‐based studies of prophylaxis in boys and advising on the role of prophylaxis in adults with SHA.1 This guideline builds on the former, accepting the clear evidence of benefit of prophylaxis in children with SHA. It addresses the optimum use of prophylaxis in children and adults with haemophilia A and B and gives evidence‐based recommendations where appropriate. The guidance will be of value to healthcare professionals, laboratory scientists, patients and those with a responsibility for funding services.
Dr Rachel Rayment is a Consultant Haematologist; Haemophilia and Thrombosis Centre Director as well as Clinical Lead for ITP at the Cardiff and Vale University Hospital Health Board.
The use of next-generation sequencing in the diagnosis of rare inherited anaemias: A Joint BSH/EHA Good Practice Paper
Guidelines for the Laboratory diagnosis of malaria
Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias
Good Practice Paper for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children
Guidelines on the diagnosis and management of Waldenström macroglobulinaemia
Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma)
Guideline on The management of Castleman disease
Good Practice Paper Richter transformation of chronic lymphocytic leukaemia
Good Practice Paper: Cytomegalovirus serological testing in potential allogeneic haematopoietic stem cell transplant recipients
Good Practice Paper: Management of cardiovascular complications of bruton tyrosine kinase inhibitors (BTKi)
Guidelines for the clinical and laboratory diagnosis of heritable platelet disorders in adults and children
Guideline on Management of sickle cell disease in pregnancy
Guidelines for the management of adult myelodysplastic syndromes
BSH ASM: Guidelines Session Question and Answer for General Haematology Presentations
BSH ASM: Guidelines Session Presentation GPP The use genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders
BSH ASM: Guidelines Session Presentation GL Management of sickle cell disease in pregnancy
BSH ASM: Guidelines Session Question and Answer for Haemostasis and Thrombosis Presentation
BSH ASM: Guidelines Session Presentation GL The Assessment of bleeding risk prior to surgery or invasive procedures by Will Lester
BSH ASM: Guideline Session Presentation GL Laboratory investigation of heritable disorders of platelets function by Keith Gomez
Good Practice Paper Preoperative patient blood management during the SARS-CoV-2 pandemic
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
Precision Medicine Forum Podcast
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive